Katherine Stueland

Chief Executive Officer at GeneDx Holdings Corp.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: GeneDx Holdings Corp., 3 years.

GeneDx Holdings Corp. Director · CHIEF EXECUTIVE OFFICER
3 years · Since 2023

Chief executive roles

GeneDx Holdings Corp. · Chief Executive Officer
Dates unknown

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 16, 2026 GeneDx Holdings Corp. Option exercise +18,750 — —
Sep 16, 2026 GeneDx Holdings Corp. Open-market sale −1,648 $94.26 $155,340
Sep 16, 2026 GeneDx Holdings Corp. Open-market sale −148 $95.41 $14,121
Sep 16, 2026 GeneDx Holdings Corp. Open-market sale −1,525 $96.90 $147,773
Sep 16, 2026 GeneDx Holdings Corp. Open-market sale −4,141 $98.27 $406,936
Sep 16, 2026 GeneDx Holdings Corp. Open-market sale −3,039 $99.00 $300,861
Sep 9, 2026 GeneDx Holdings Corp. Option exercise +6,547 — —
Sep 9, 2026 GeneDx Holdings Corp. Open-market sale −3,692 $84.22 $310,940
Jun 16, 2026 GeneDx Holdings Corp. Option exercise +18,750 — —
Jun 16, 2026 GeneDx Holdings Corp. Open-market sale −2,140 $59.75 $127,865
Jun 16, 2026 GeneDx Holdings Corp. Open-market sale −5,932 $60.83 $360,844
Jun 16, 2026 GeneDx Holdings Corp. Open-market sale −2,429 $61.50 $149,384
Jun 9, 2026 GeneDx Holdings Corp. Option exercise +6,546 — —
Jun 9, 2026 GeneDx Holdings Corp. Open-market sale −3,639 $53.77 $195,669
Apr 29, 2026 GeneDx Holdings Corp. Option exercise +3,874 — —

Questions about Katherine Stueland

What boards is Katherine Stueland on?

Katherine Stueland sits on the board of GeneDx Holdings Corp.

What company is Katherine Stueland the CEO of?

Katherine Stueland is Chief Executive Officer of GeneDx Holdings Corp.

How long has Katherine Stueland served on boards?

Our records show at least 4 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.